07:00 , Apr 15, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease Blindness Bardet-Biedl syndrome 3 (BBS3) A study in zebrafish and in mice suggests that increasing expression of the BBS3 long isoform could help...